ZNF133 and ovarian carcinoma: Using 31 gene-tissue pairs in which a cancer gene is epigenetically silenced in >1% of samples, only one significant two-way interaction between promoter DNA hypermethylation and CNA loss–ZNF133 in ovarian cancer—was identified (FDR 10%; Supplementary Fig. 7b; Supplementary Data 2).